Titan Pharmaceuticals
TTNP
#10403
Rank
HK$47.78 M
Marketcap
HK$35.92
Share price
-3.76%
Change (1 day)
38.13%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.21. In 2023 the company made an earnings per share (EPS) of -HK$57.74 an increase over its 2022 EPS that were of -HK$118.36.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$57.74-51.22%
2022-HK$118.36-15.61%
2021-HK$140.26-81.37%
2020-HK$752.71-77.52%
2019-HK$3,349-56.32%
2018-HK$7,667-59.51%
2017-HK$18,938-371.81%
2016HK$6,967-144.35%
2015-HK$15,709300%
2014-HK$3,927-121.54%
2013HK$18,233-151.38%
2012-HK$35,485-11.54%
2011-HK$40,114188.89%
2010-HK$13,885-10%
2009-HK$15,428
2007-HK$63,256-2.38%
2006-HK$64,799-39.13%
2005-HK$106,455-16.87%
2004-HK$128,055-22.43%
2003-HK$165,0834.9%
2002-HK$157,36961.9%
2001-HK$97,198-13.7%
2000-HK$112,62765.01%
1999-HK$68,256-35.87%
1998-HK$106,437-1824.71%
1997HK$6,171-102.4%
1996-HK$257,653

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-HK$11.06-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.95-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.34-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.34-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.35-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
HK$0.23-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA